This company announced key business information that will help them to boost their revenue and tap the ever-growing needs of the fintech industry. In this article, we will dive deep into the information announced by this company.

Price Movement

With a market capitalization of Rs 74,813 crore, the shares of PB Fintech Ltd made a 52-week high of Rs 2,246.90 per share, down by 27 percent from its current market price of Rs 1,631 per share. The stock has given a negative return of 4.2 percent over the last six months. 

About the announcement

On Tuesday, PB Fintech, the parent entity of Policybazaar, announced that its subsidiary PB Pay Private Limited has received the RBI’s nod for payment aggregator licence.

The company said in a regulatory filing that it received the approval under the Payment and Settlement Systems Act, 2007, and was communicated via an RBI letter dated April 15, 2025.

PB Pay was incorporated with the aim of becoming a Non-Banking Financial Company – Payment Aggregator (NBFC-PA). The company had earlier notified exchanges regarding the incorporation of PB Pay in disclosures on March 20 and April 9, 2024.

Financial Highlights

The company reported a revenue of Rs 1,292 crore in Q3 FY25, up by 48 percent, from its Q3 FY24 revenue of Rs 871 crore. It posted a net profit of Rs 72 crore in Q3 FY25, up by 94 percent, from its Q3 FY24 net profit of Rs 37 crores, and up by 41 percent from its Q2 FY25 net profit of Rs 51 crores. 

Payment Aggregator Industry

Paytm, Razorpay, Cashfree payments, PayU, etc, are the leading payment aggregators in India as of April 2025. The industry is estimated at USD 1.42 billion in 2025 and is projected to reach USD 3.13 billion by 2030, growing at a CAGR of 17.16 percent.

About the Company

PB Fintech Limited, established in 2008 with headquarters in Gurugram, India, runs online platforms for insurance and lending. Its key platforms are Policybazaar, for insurance comparison and purchase, and Paisabazaar, for loans and credit products. The organization also provides healthcare support, marketing, consulting, claims support, and distribution of insurance services in India and internationally.

Written by Satyajeet Mukherjee

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

×